National Health Investors Inc. (NHI) Stock Rating Upgraded by Zacks Investment Research
National Health Investors Inc. (NYSE:NHI) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Tuesday. The firm currently has a $84.00 price target on the real estate investment trust’s stock. Zacks Investment Research’s price objective would suggest a potential upside of 10.12% from the company’s previous close.
According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “
A number of other equities research analysts also recently issued reports on NHI. Cantor Fitzgerald initiated coverage on shares of National Health Investors in a research report on Thursday, June 23rd. They issued a “hold” rating and a $70.00 target price for the company. Mizuho increased their price target on shares of National Health Investors from $66.00 to $77.00 and gave the stock a “neutral” rating in a research note on Monday, August 8th. Wells Fargo & Co. restated a “hold” rating on shares of National Health Investors in a research note on Sunday, September 4th. Finally, Stephens started coverage on shares of National Health Investors in a research note on Wednesday, September 14th. They set an “overweight” rating and a $84.00 price target on the stock. Five equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $73.86.
National Health Investors (NYSE:NHI) opened at 76.28 on Tuesday. National Health Investors has a one year low of $54.51 and a one year high of $82.53. The firm has a 50-day moving average of $78.83 and a 200-day moving average of $73.90. The firm has a market cap of $2.99 billion, a price-to-earnings ratio of 17.59 and a beta of 0.61.
National Health Investors (NYSE:NHI) last released its earnings results on Friday, August 5th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.21 by $0.01. National Health Investors had a net margin of 69.69% and a return on equity of 14.68%. The company earned $61.20 million during the quarter, compared to the consensus estimate of $58.08 million. During the same quarter in the prior year, the firm earned $1.17 EPS. The company’s revenue was up 8.7% compared to the same quarter last year. Analysts anticipate that National Health Investors will post $4.88 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Thursday, November 10th. Investors of record on Friday, September 30th will be paid a $0.90 dividend. The ex-dividend date of this dividend is Wednesday, September 28th. This represents a $3.60 dividend on an annualized basis and a yield of 4.72%. National Health Investors’s payout ratio is presently 82.95%.
In related news, Director Robert A. Mccabe, Jr. sold 800 shares of the firm’s stock in a transaction on Tuesday, August 30th. The shares were sold at an average price of $80.29, for a total value of $64,232.00. Following the transaction, the director now directly owns 10,021 shares in the company, valued at approximately $804,586.09. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 5.74% of the stock is currently owned by corporate insiders.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Societe Generale purchased a new position in National Health Investors during the second quarter worth about $103,000. Creative Planning raised its stake in National Health Investors by 2.6% in the second quarter. Creative Planning now owns 1,390 shares of the real estate investment trust’s stock valued at $104,000 after buying an additional 35 shares in the last quarter. BlackRock Japan Co. Ltd raised its stake in National Health Investors by 1.1% in the first quarter. BlackRock Japan Co. Ltd now owns 1,809 shares of the real estate investment trust’s stock valued at $120,000 after buying an additional 20 shares in the last quarter. BNP Paribas Arbitrage SA raised its stake in National Health Investors by 6,303.6% in the second quarter. BNP Paribas Arbitrage SA now owns 1,793 shares of the real estate investment trust’s stock valued at $135,000 after buying an additional 1,765 shares in the last quarter. Finally, Huntington Asset Advisors Inc. bought a new stake in National Health Investors during the first quarter valued at about $166,000. Institutional investors and hedge funds own 67.49% of the company’s stock.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.